Second primary cutaneous melanoma in patients with advanced melanoma treated with anti‐programmed‐death‐receptor‐1 monoclonal antibodies. (1st April 2021) - Charvet, E.; Kramkimel, N.; Chaplain, L.; Gantzer, A.; Kassem, O.; Longvert, C.; Blom, A.; Dupin, N.; Aractingi, S.; Hamon, M.; Zimmermann, U.; Emile, J.‐F.; et al.